tiprankstipranks
Utah Medical Products (UTMD)
NASDAQ:UTMD
US Market
UTMD
Utah Medical Products
RESEARCH TOOLSreports
Want to see UTMD full AI Analyst Report?

Utah Medical Products (UTMD) Ratios

121 Followers

Utah Medical Products Ratios

UTMD's free cash flow for Q4 2025 was $0.52. For the 2025 fiscal year, UTMD's free cash flow was decreased by $ and operating cash flow was $0.34. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 28.64 37.62 25.64 22.56 15.09
Quick Ratio
 26.15 34.57 23.29 20.53 13.61
Cash Ratio
 24.94 33.01 22.09 19.72 12.59
Solvency Ratio
 3.27 4.35 3.26 3.22 2.45
Operating Cash Flow Ratio
 4.19 5.66 3.95 4.73 3.55
Short-Term Operating Cash Flow Coverage
 0.00 0.00 264.84 0.00 0.00
Net Current Asset Value
$ 96.37M$ 94.47M$ 91.22M$ 99.12M$ 80.30M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.03 1.03 1.04 1.06 1.08
Debt Service Coverage Ratio
 0.00 0.00 241.29 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 <0.01 0.00 0.00
Interest Debt Per Share
 0.07 0.07 0.10 0.08 0.09
Net Debt to EBITDA
 -5.79 -5.01 -5.03 -3.74 -2.78
Profitability Margins
Gross Profit Margin
53.63%51.60%59.03%59.81%61.58%
EBIT Margin
34.15%36.63%33.23%36.71%37.85%
EBITDA Margin
40.12%44.29%40.19%49.28%51.40%
Operating Profit Margin
28.81%29.60%33.23%33.40%37.85%
Pretax Profit Margin
35.79%36.63%41.08%40.00%39.52%
Net Profit Margin
28.90%29.30%33.92%33.12%31.51%
Continuous Operations Profit Margin
28.90%29.30%33.92%33.12%31.51%
Net Income Per EBT
80.76%79.99%82.57%82.81%79.74%
EBT Per EBIT
124.21%123.75%123.60%119.74%104.39%
Return on Assets (ROA)
8.72%9.21%11.32%12.28%13.30%
Return on Equity (ROE)
9.13%9.46%11.81%12.96%14.42%
Return on Capital Employed (ROCE)
8.95%9.51%11.44%12.83%16.78%
Return on Invested Capital (ROIC)
7.23%7.60%9.45%10.63%13.38%
Return on Tangible Assets
9.85%10.48%13.08%14.24%16.45%
Earnings Yield
5.27%6.09%6.44%5.43%4.51%
Efficiency Ratios
Receivables Turnover
 10.32 10.94 9.99 14.82 9.44
Payables Turnover
 14.57 20.47 30.87 26.25 16.49
Inventory Turnover
 2.00 2.35 1.90 2.11 2.28
Fixed Asset Turnover
 3.86 3.89 4.19 4.76 5.11
Asset Turnover
 0.30 0.31 0.33 0.37 0.42
Working Capital Turnover Ratio
 0.39 0.41 0.42 0.54 0.68
Cash Conversion Cycle
 193.26 170.88 216.62 183.99 176.70
Days of Sales Outstanding
 35.36 33.37 36.53 24.64 38.66
Days of Inventory Outstanding
 182.94 155.34 191.91 173.26 160.17
Days of Payables Outstanding
 25.04 17.83 11.83 13.90 22.13
Operating Cycle
 218.30 188.71 228.44 197.90 198.84
Cash Flow Ratios
Operating Cash Flow Per Share
 4.61 4.44 4.23 6.13 5.81
Free Cash Flow Per Share
 4.50 4.33 4.17 5.95 5.59
CapEx Per Share
 0.12 0.11 0.07 0.18 0.22
Free Cash Flow to Operating Cash Flow
 0.97 0.97 0.98 0.97 0.96
Dividend Paid and CapEx Coverage Ratio
 3.37 3.37 3.30 4.53 5.31
Capital Expenditure Coverage Ratio
 39.60 39.60 63.11 34.87 25.85
Operating Cash Flow Coverage Ratio
 69.96 65.30 43.88 75.53 62.01
Operating Cash Flow to Sales Ratio
 0.39 0.38 0.36 0.44 0.40
Free Cash Flow Yield
6.95%7.73%6.78%7.07%5.56%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.98 16.41 15.52 18.41 22.20
Price-to-Sales (P/S) Ratio
 5.49 4.81 5.26 6.10 6.99
Price-to-Book (P/B) Ratio
 1.71 1.55 1.83 2.39 3.20
Price-to-Free Cash Flow (P/FCF) Ratio
 14.38 12.93 14.75 14.15 17.99
Price-to-Operating Cash Flow Ratio
 14.02 12.61 14.52 13.75 17.29
Price-to-Earnings Growth (PEG) Ratio
 -1.58 -1.18 -1.16 20.85 1.87
Price-to-Fair Value
 1.71 1.55 1.83 2.39 3.20
Enterprise Value Multiple
 7.88 5.84 8.07 8.63 10.83
Enterprise Value
 118.72M 99.70M 132.69M 213.72M 290.92M
EV to EBITDA
 7.88 5.84 8.07 8.63 10.83
EV to Sales
 3.16 2.59 3.24 4.26 5.56
EV to Free Cash Flow
 8.29 6.96 9.09 9.88 14.31
EV to Operating Cash Flow
 8.08 6.79 8.95 9.59 13.76
Tangible Book Value Per Share
 33.31 31.53 28.83 30.16 24.89
Shareholders’ Equity Per Share
 37.79 36.03 33.52 35.28 31.41
Tax and Other Ratios
Effective Tax Rate
 0.19 0.20 0.17 0.17 0.20
Revenue Per Share
 11.78 11.64 11.68 13.81 14.37
Net Income Per Share
 3.41 3.41 3.96 4.57 4.53
Tax Burden
 0.81 0.80 0.83 0.83 0.80
Interest Burden
 1.05 1.00 1.24 1.09 1.04
Research & Development to Revenue
 0.02 0.02 0.02 0.01 <0.01
SG&A to Revenue
 0.23 0.20 0.14 0.22 0.20
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.30 1.30 1.07 1.34 1.28
Currency in USD